Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 1.020
+0.048 (4.94%)
Jan 12, 2026, 11:43 AM CET
Transgene Market Cap
Transgene has a market cap or net worth of €266.16 million as of January 12, 2026. Its market cap has increased by 196.55% in one year.
Market Cap
266.16M
Enterprise Value
280.45M
Revenue
7.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.02
Market Cap Chart
Since March 30, 1998, Transgene's market cap has increased from 151.86M to 266.16M, an increase of 75.27%. That is a compound annual growth rate of 2.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 266.16M | 1.25% |
| Dec 31, 2025 | 262.87M | 192.89% |
| Dec 31, 2024 | 89.75M | -34.86% |
| Dec 29, 2023 | 137.78M | -16.38% |
| Dec 30, 2022 | 164.76M | -33.52% |
| Dec 31, 2021 | 247.84M | 79.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 100.86B |
| Sartorius Stedim Biotech | 21.47B |
| bioMérieux | 13.42B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.40B |
| ABIVAX Société Anonyme | 7.72B |
| Virbac | 3.03B |